new formulations of Actonel and Fosamax and a new bisphosphonate called Reclast

June 2007

Drug companies will promote new formulations of Actonel and Fosamax and a new bisphosphonate called Reclast.

It's a competitive market. There are a huge number of potential patients...and many dollars at stake.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote